Recurrent Gastrointestinal Bleeding

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Recurrent Gastrointestinal Bleeding trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT03675672

Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer

Patients with a history of idiopathic gastroduodenal ulcer bleeding face an increased risk of recurrent ulcer gastrointestinal bleeding. Our ongoing clinical tr…

Hong Kong154 participantsStarted 2018-06-21

Treatment: Misoprostol Oral Tablet, Placebo Oral Tablet

All recent trials (37 shown)

TerminatedPhase 3

NCT05171075

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) r…

United States417 participantsStarted 2022-09-27

Treatment: Abelacimab, Dalteparin

CompletedPhase 2

NCT03499808

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment. Monoclo…

United States43 participantsStarted 2018-06-06

Treatment: Isatuximab, Laboratory Biomarker Analysis

Recurrent Gastrointestinal Bleeding

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer

All recent trials (37 shown)

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer

All recent trials (37 shown)

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Left Atrial Appendage Closure With WATCHMAN FLX Device in Recurrent Gastrointestinal Bleeding: The GI-FLX Registry

Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease

The Efficacy of Aescin in Combination With Micronized Purified Flavonoid Fraction (MPFF) in the Control of Bleeding and…

Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism

Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy

Balloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding

the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation

Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding

Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients

the Efficiency of Endoscopic Treatment for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malforma…

PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers

Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension

Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding

Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers

ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA

Study of Hemospray for Lower Gastrointestinal Hemorrhage

Preventing Recurrent Bleeding After Eradication of Esophageal Varices

Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation